Probiotic VSL#3 prevents antibiotic-associated diarrhoea in a double-blind, randomized, placebo-controlled clinical trial.

FTA

One sachet of VSL#3 or placebo was given twice daily for the length of the antibiotics course and for seven days thereafter [ … ] The rate of AAD [Antibiotic-associated diarrhoea] was significantly lower in the active group on per protocol analysis (0% active vs 11.4% placebo; P = 0.006).